QA: Biohaven Pharmaceutical Holding Co Ltd in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001689813_2019_Biohaven_Pharmaceutical_Holding_Co_Ltd.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001689813, Biohaven Pharmaceutical Holding Co Ltd

  xvar xval
0 AssetsCurrent 272,339,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,248,000
3 remainder_Assets 11,425,000
4 LiabilitiesCurrent 19,534,000
5 LiabilitiesNoncurrent 2,043,000
6 remainder_Liabilities 117,515,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 34,603,000
9 ResearchAndDevelopmentExpense 189,951,000
10 remainder_Expenses 467,000
11 remainder_Revenues 0
12 remainder_NetIncome -15,901,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 290,012,000
1 Liabilities 139,092,000
2 Expenses 225,021,000
3 Revenues 0
4 StockholdersEquity 150,920,000
5 NetIncome -240,922,000
6 ComprehensiveNetIncome -240,922,000
7 BaseVar 335,013,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.411
9 EconomicCapitalRatio 1.80

Edgar->Model Mapping

Feature Distribution

Change over Time